We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.38B
AUM Growth
+$231M
Cap. Flow
+$238M
Cap. Flow %
3.22%
Top 10 Hldgs %
23.76%
Holding
443
New
26
Increased
211
Reduced
155
Closed
11

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$135M
2
PEP icon
PepsiCo
PEP
+$65.3M
3
PNC icon
PNC Financial Services
PNC
+$61.9M
4
HD icon
Home Depot
HD
+$55.7M
5
HAS icon
Hasbro
HAS
+$48M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$80.6M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.1M
3
USB icon
US Bancorp
USB
+$65.3M
4
MCD icon
McDonald's
MCD
+$50.1M
5
OKE icon
Oneok
OKE
+$49.8M

Sector Composition

Rank Sector Weight
1 Healthcare 16.18%
2 Consumer Staples 15.63%
3 Technology 14.71%
4 Financials 12.61%
5 Industrials 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACH
351
Accendra Health
ACH
$214M
$342K ﹤0.01%
10,110
+190
+2% +$6.62K
EEP
352
DELISTED
Enbridge Energy Partners
EEP
$341K ﹤0.01%
9,475
+1,000
+12% +$38.3K
SRE icon
353
Sempra
SRE
$54.8B
$338K ﹤0.01%
+6,200
New +$342K
MPC icon
354
Marathon Petroleum
MPC
$83.7B
$336K ﹤0.01%
6,568
+400
+6% +$19.2K
MCRL
355
DELISTED
MICREL INC
MCRL
$334K ﹤0.01%
22,168
+700
+3% +$10.2K
PID icon
356
Invesco International Dividend Achievers ETF
PID
$919M
$333K ﹤0.01%
19,070
BA icon
357
Boeing
BA
$185B
$332K ﹤0.01%
2,215
+30
+1% +$4.37K
VTI icon
358
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$329K ﹤0.01%
3,064
+64
+2% +$6.83K
BIP icon
359
Brookfield Infrastructure Partners
BIP
$18B
$328K ﹤0.01%
18,144
OXY icon
360
Occidental Petroleum
OXY
$55.9B
$324K ﹤0.01%
4,438
+782
+21% +$60.5K
C icon
361
Citigroup
C
$226B
$319K ﹤0.01%
6,186
+561
+10% +$28.6K
VIVO
362
DELISTED
Meridian Bioscience Inc
VIVO
$311K ﹤0.01%
16,300
-5,630
-26% -$104K
NEOG icon
363
Neogen
NEOG
$2.5B
$308K ﹤0.01%
17,552
+680
+4% +$12.5K
PII icon
364
Polaris
PII
$4.07B
$308K ﹤0.01%
2,185
-400
-15% -$58.9K
MCO icon
365
Moody's
MCO
$82.7B
$307K ﹤0.01%
2,960
+400
+16% +$38.7K
BIIB icon
366
Biogen
BIIB
$30.7B
$304K ﹤0.01%
+719
New +$283K
DGS icon
367
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.77B
$303K ﹤0.01%
6,848
-350
-5% -$15.4K
REIS
368
DELISTED
Reis, Inc.
REIS
$299K ﹤0.01%
+11,660
New +$284K
BUD icon
369
AB InBev
BUD
$165B
$291K ﹤0.01%
2,390
-3,510
-59% -$424K
HIW icon
370
Highwoods Properties
HIW
$3.47B
$288K ﹤0.01%
6,300
D icon
371
Dominion Energy
D
$59.3B
$286K ﹤0.01%
4,032
+395
+11% +$29.3K
RAVN
372
DELISTED
Raven Industries Inc
RAVN
$283K ﹤0.01%
13,841
+355
+3% +$7.68K
ABB
373
DELISTED
ABB Ltd
ABB
$281K ﹤0.01%
13,250
-931
-7% -$19.2K
LHO
374
DELISTED
LaSalle Hotel Properties
LHO
$280K ﹤0.01%
7,208
AON icon
375
Aon
AON
$76B
$279K ﹤0.01%
+2,902
New +$281K

Similar funds

Bahl & Gaynor's Q1 2015 Portfolio in Review

As of Q1 2015, Bahl & Gaynor held 443 positions worth $7.38B, up 3.2% from $7.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Bahl & Gaynor deployed $238M of net new capital in Q1 2015, opening 26 new positions and adding to 211 existing holdings. Its largest new stake was Blackstone: 24,777 shares worth $946K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Baxter International, an estimated $80.6M trimmed.

  • Bahl & Gaynor's largest Q1 2015 buy was Blackstone: 24,777 shares worth $946K.
  • Bahl & Gaynor added most to Pfizer in Q1 2015, an estimated $135M increase.
  • Bahl & Gaynor's biggest Q1 2015 reduction was Baxter International, cutting an estimated $80.6M.
  • Bahl & Gaynor fully exited MWI VETERINARY SUPPLY, INC. in Q1 2015, selling an estimated $650K.
  • Bahl & Gaynor's ten largest holdings make up 24% of its $7.38B portfolio in Q1 2015.
  • Bahl & Gaynor opened 26 new positions and closed 11 in Q1 2015.
  • Bahl & Gaynor's portfolio value rose 3.2% quarter-over-quarter to $7.38B.

Based on Bahl & Gaynor's 13F filing for Q1 2015, filed 12 May 2015.